Literature DB >> 17934094

Joint remodelling in inflammatory disease.

Georg Schett1.   

Abstract

Bone and the immune system share multiple interactions. The skeleton harbours the bone marrow and provides the niche for development of haematopoietic cells including the immune system. The immune system provides cells as well as molecular signals, which regulate bone homeostasis. Understanding the cellular and molecular regulation of the tight interaction between bone and the immune system is crucial for understanding the changes of skeletal architecture during inflammation. Whereas a short and self-limited activation of the immune system has no clinically meaningful effect on bone, prolonged immune activation as found in chronic inflammatory disease inevitably leads to bone wasting.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17934094      PMCID: PMC2095295          DOI: 10.1136/ard.2007.078972

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  29 in total

1.  Novel mechanism of Wnt signalling inhibition mediated by Dickkopf-1 interaction with LRP6/Arrow.

Authors:  A Bafico; G Liu; A Yaniv; A Gazit; S A Aaronson
Journal:  Nat Cell Biol       Date:  2001-07       Impact factor: 28.824

2.  Interleukin-4 reversibly inhibits osteoclastogenesis via inhibition of NF-kappa B and mitogen-activated protein kinase signaling.

Authors:  Shi Wei; Michael W-H Wang; Steven L Teitelbaum; F Patrick Ross
Journal:  J Biol Chem       Date:  2001-11-21       Impact factor: 5.157

3.  Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand.

Authors:  Y Y Kong; U Feige; I Sarosi; B Bolon; A Tafuri; S Morony; C Capparelli; J Li; R Elliott; S McCabe; T Wong; G Campagnuolo; E Moran; E R Bogoch; G Van; L T Nguyen; P S Ohashi; D L Lacey; E Fish; W J Boyle; J M Penninger
Journal:  Nature       Date:  1999-11-18       Impact factor: 49.962

Review 4.  Bone resorption by osteoclasts.

Authors:  S L Teitelbaum
Journal:  Science       Date:  2000-09-01       Impact factor: 47.728

5.  Expression of osteoclast differentiation factor in rheumatoid arthritis.

Authors:  Y Shigeyama; T Pap; P Kunzler; B R Simmen; R E Gay; S Gay
Journal:  Arthritis Rheum       Date:  2000-11

6.  TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand.

Authors:  J Lam; S Takeshita; J E Barker; O Kanagawa; F P Ross; S L Teitelbaum
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

7.  IL-17 promotes bone erosion in murine collagen-induced arthritis through loss of the receptor activator of NF-kappa B ligand/osteoprotegerin balance.

Authors:  Erik Lubberts; Liduine van den Bersselaar; Birgitte Oppers-Walgreen; Paul Schwarzenberger; Christina J J Coenen-de Roo; Jay K Kolls; Leo A B Joosten; Wim B van den Berg
Journal:  J Immunol       Date:  2003-03-01       Impact factor: 5.422

8.  Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis.

Authors:  Christopher T Ritchlin; Sally A Haas-Smith; Ping Li; David G Hicks; Edward M Schwarz
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

9.  Treg cells suppress osteoclast formation: a new link between the immune system and bone.

Authors:  Mario M Zaiss; Roland Axmann; Jochen Zwerina; Karin Polzer; Eva Gückel; Alla Skapenko; Hendrik Schulze-Koops; Nikki Horwood; Andrew Cope; Georg Schett
Journal:  Arthritis Rheum       Date:  2007-12

Review 10.  The Wnts.

Authors:  Jeffrey R Miller
Journal:  Genome Biol       Date:  2001-12-28       Impact factor: 13.583

View more
  17 in total

Review 1.  The balance of tissue repair and remodeling in chronic arthritis.

Authors:  Rik Lories
Journal:  Nat Rev Rheumatol       Date:  2011-10-18       Impact factor: 20.543

Review 2.  TNF and Bone Remodeling.

Authors:  Baohong Zhao
Journal:  Curr Osteoporos Rep       Date:  2017-06       Impact factor: 5.096

Review 3.  TLRs, future potential therapeutic targets for RA.

Authors:  Hatem A Elshabrawy; Abdul E Essani; Zoltán Szekanecz; David A Fox; Shiva Shahrara
Journal:  Autoimmun Rev       Date:  2016-12-15       Impact factor: 9.754

Review 4.  Progress in spondylarthritis. Immunopathogenesis of spondyloarthritis: which cells drive disease?

Authors:  Lode Melis; Dirk Elewaut
Journal:  Arthritis Res Ther       Date:  2009-06-25       Impact factor: 5.156

5.  Ligation of TLR5 promotes myeloid cell infiltration and differentiation into mature osteoclasts in rheumatoid arthritis and experimental arthritis.

Authors:  Seung-Jae Kim; Zhenlong Chen; Nathan D Chamberlain; Abdul B Essani; Michael V Volin; M Asif Amin; Suncica Volkov; Ellen M Gravallese; Shiva Arami; William Swedler; Nancy E Lane; Anjali Mehta; Nadera Sweiss; Shiva Shahrara
Journal:  J Immunol       Date:  2014-09-08       Impact factor: 5.422

6.  Assessment of synovitis to predict bone erosions in rheumatoid arthritis.

Authors:  Serena Bugatti; Antonio Manzo; Roberto Caporali; Carlomaurizio Montecucco
Journal:  Ther Adv Musculoskelet Dis       Date:  2012-08       Impact factor: 5.346

7.  ERAP1 genetic variations associated with HLA-B27 interaction and disease severity of syndesmophytes formation in Taiwanese ankylosing spondylitis.

Authors:  Chin-Man Wang; Huei-Huang Ho; Su-Wei Chang; Yeong-Jian Jan Wu; Jing-Chi Lin; Pi-Yueh Chang; Jianming Wu; Ji-Yih Chen
Journal:  Arthritis Res Ther       Date:  2012-05-25       Impact factor: 5.156

8.  Biomarkers and cytokines of bone turnover: extensive evaluation in a cohort of patients with ankylosing spondylitis.

Authors:  Ali Taylan; Ismail Sari; Baris Akinci; Safak Bilge; Didem Kozaci; Servet Akar; Ayfer Colak; Hulya Yalcin; Necati Gunay; Nurullah Akkoc
Journal:  BMC Musculoskelet Disord       Date:  2012-10-02       Impact factor: 2.362

9.  Circulating protein fragments of cartilage and connective tissue degradation are diagnostic and prognostic markers of rheumatoid arthritis and ankylosing spondylitis.

Authors:  Anne C Bay-Jensen; Stephanie Wichuk; Inger Byrjalsen; Diana J Leeming; Nathalie Morency; Claus Christiansen; Morten A Karsdal; Walter P Maksymowych
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

Review 10.  How to translate basic knowledge into clinical application of biologic therapy in spondyloarthritis.

Authors:  Chung-Tei Chou
Journal:  Clin Dev Immunol       Date:  2013-06-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.